FAB-144

FAB-144
Legal status
Legal status	CA: Schedule II ; DE: NpSG (Industrial and scientific use only) ; UK: Under Psychoactive Substances Act ;
Identifiers
	IUPAC name 1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indazole;
PubChem CID	102135350;
ChemSpider	32055552;
Chemical and physical data
Formula	C20H27FN2O
Molar mass	330.4 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES FCCCCCN1N=C(C(C2C(C)(C)C2(C)C)=O)C3=C1C=CC=C3;
	InChI InChI=1S/C20H27FN2O/c1-19(2)18(20(19,3)4)17(24)16-14-10-6-7-11-15(14)23(22-16)13-9-5-8-12-21/h6-7,10-11,18H,5,8-9,12-13H2,1-4H3; Key:LVJQJRUAYXVEGN-UHFFFAOYSA-N;

FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB₁ receptor and has been sold online as a designer drug.[1] It is the indazole analogue of XLR-11.

Legal status

Sweden's public health agency suggested classifying FAB-144 as hazardous substance on November 10, 2014.[2]

References

"FAB-144". Cayman Chemical. Retrieved 23 July 2015.
"Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "FAB-144". Cayman Chemical. Retrieved 23 July 2015.

[2] "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.

FAB-144

Legal status

See also

References